Metabolys
Lyons, FR· latest recorded location
METABOLYS is named on 4 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 4
- Published applications
- 4
- Inventors
- 4
- Granted in 2026 so far
- 0
- Most recent grant
- 10 May 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 2 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
By publication year.
Technology areas
Share of 8 documents
Recent patents
- Treatment for the non alcoholic steatohepatitis and fibrosis10 May 2022US 11,324,743 B2
- Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes17 Jan 2017US 9,545,387 B2
- Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance6 Oct 2015US 9,150,523 B2
- Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance6 Oct 2015US 9,150,529 B2
- New treatment for the non alcoholic steatohepatitis and fibrosis30 May 2019US 2019/0160057 A1
- Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes22 Oct 2015US 2015/0297539 A1
- Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance21 Aug 2014US 2014/0235650 A1
- Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance5 Jun 2014US 2014/0155409 A1
Most cited
By later US patents
- Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance1US 9,150,523 B22015
- Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance1US 9,150,529 B22015
- Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes1US 9,545,387 B22017